Breaking News Instant updates and real-time market news.

PLAY

Dave & Buster's

$36.80 /

-5.7 (-13.41%)

07:54
09/11/19
09/11
07:54
09/11/19
07:54

Dave & Buster's downgraded on deteriorating comps at Raymond James

Raymond James analyst Brian Vaccaro downgraded Dave & Buster's to Market Perform from Outperform, citing a recent further deterioration in comps that offsets the stock's low valuation and potential activists. While management communicated several near-term initiatives to revitalize the brand, streamline costs, and work towards a more flexible new unit growth pipeline, Vaccaro tells investors in a research note that increased competition remains a primary headwind.

PLAY Dave & Buster's
$36.80 /

-5.7 (-13.41%)

09/11/19 BMO Capital
Dave & Buster's price target lowered to $50 from $55 at BMO Capital
09/11/19 Loop Capital
Dave & Buster's downgraded to Hold from Buy at Loop Capital
09/11/19 Wells Fargo
Dave & Buster's price target lowered to $40 from $46 at Wells Fargo
09/11/19 Piper Sandler
Dave & Buster's price target lowered to $40 from $55 at Piper Jaffray

TODAY'S FREE FLY STORIES

Recommendations
Regeneron antibody cocktail important in beating COVID, says Canaccord » 08:15
08/10/20
08/10
08:15
08/10/20
08:15
REGN

Regeneron

$620.43 /

-0.7 (-0.11%)

Canaccord analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$620.43 /

-0.7 (-0.11%)

REGN Regeneron
$620.43 /

-0.7 (-0.11%)

08/06/20 Oppenheimer
Regeneron price target raised to $725 from $675 at Oppenheimer
08/06/20 BMO Capital
Regeneron price target raised to $626 from $525 at BMO Capital
08/06/20 Barclays
Regeneron price target raised to $675 from $615 at Barclays
08/05/20 Piper Sandler
Regeneron price target raised to $675 from $630 at Piper Sandler
REGN Regeneron
$620.43 /

-0.7 (-0.11%)

  • 27
    May
REGN Regeneron
$620.43 /

-0.7 (-0.11%)

REGN Regeneron
$620.43 /

-0.7 (-0.11%)

REGN Regeneron
$620.43 /

-0.7 (-0.11%)

Hot Stocks
AnaptysBio expects cash, cash quivalents to fund plan at least into 2023 » 08:14
08/10/20
08/10
08:14
08/10/20
08:14
ANAB

AnaptysBio

$18.51 /

+0.7 (+3.93%)

AnaptysBio expects its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

01/16/20 Cantor Fitzgerald
AnaptysBio risk/reward favorable into second half data, says Cantor Fitzgerald
11/11/19 SunTrust
AnaptysBio downgraded to Hold from Buy at SunTrust
11/08/19 Cantor Fitzgerald
Cantor cuts AnaptysBio target to $28 from $140, sees value in shares
11/08/19 Jefferies
AnaptysBio downgraded to Hold from Buy at Jefferies
ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

Earnings
AnaptysBio reports Q2 EPS (79c), consensus (75c) » 08:14
08/10/20
08/10
08:14
08/10/20
08:14
ANAB

AnaptysBio

$18.51 /

+0.7 (+3.93%)

Reports Q revenue $15M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

01/16/20 Cantor Fitzgerald
AnaptysBio risk/reward favorable into second half data, says Cantor Fitzgerald
11/11/19 SunTrust
AnaptysBio downgraded to Hold from Buy at SunTrust
11/08/19 Cantor Fitzgerald
Cantor cuts AnaptysBio target to $28 from $140, sees value in shares
11/08/19 Jefferies
AnaptysBio downgraded to Hold from Buy at Jefferies
ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

Initiation
Swiss Re resumed with an Equal Weight at Morgan Stanley » 08:14
08/10/20
08/10
08:14
08/10/20
08:14
SSREY

Swiss Re

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSREY Swiss Re
$0.00 /

+ (+0.00%)

08/04/20 JPMorgan
Swiss Re price target lowered to CHF 93 from CHF 94 at JPMorgan
08/03/20 Deutsche Bank
Swiss Re Hold rating reaffirmed at Deutsche Bank after H1 results
07/23/20 JPMorgan
Swiss Re price target lowered to CHF 94 from CHF 96 at JPMorgan
07/07/20 JPMorgan
Swiss Re price target lowered to CHF 96 from CHF 98 at JPMorgan
SSREY Swiss Re
$0.00 /

+ (+0.00%)

SSREY Swiss Re
$0.00 /

+ (+0.00%)

Recommendations
Domtar price target raised to $26 from $21 at RBC Capital » 08:14
08/10/20
08/10
08:14
08/10/20
08:14
UFS

Domtar

$28.49 /

+6.02 (+26.79%)

RBC Capital analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UFS Domtar
$28.49 /

+6.02 (+26.79%)

UFS Domtar
$28.49 /

+6.02 (+26.79%)

06:36 Today Stephens
Domtar price target raised to $42 from $34 at Stephens
05:58 Today CIBC
Domtar downgraded to Underperformer from Neutral at CIBC
06/05/20 RBC Capital
Domtar downgraded to Sector Perform from Outperform at RBC Capital
06/05/20 RBC Capital
Domtar downgraded to Sector Perform from Outperform at RBC Capital
UFS Domtar
$28.49 /

+6.02 (+26.79%)

Hot Stocks
Leidos awarded $649M contract by ACC-APG » 08:13
08/10/20
08/10
08:13
08/10/20
08:13
LDOS

Leidos

$93.24 /

+2.23 (+2.45%)

Leidos has been awarded a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LDOS Leidos
$93.24 /

+2.23 (+2.45%)

LDOS Leidos
$93.24 /

+2.23 (+2.45%)

08/06/20 Stifel
Leidos share price reaction to earnings report 'puzzling,' says Stifel
06/11/20
Fly Intel: Top five analyst initiations
06/11/20 Baird
Baird starts Leidos at Outperform, sees growth poised to ramp next year
06/10/20 Baird
Leidos initiated with an Outperform at Baird
LDOS Leidos
$93.24 /

+2.23 (+2.45%)

LDOS Leidos
$93.24 /

+2.23 (+2.45%)

LDOS Leidos
$93.24 /

+2.23 (+2.45%)

Hot Stocks
Salesforce, CVS Health announce strategic relationship » 08:13
08/10/20
08/10
08:13
08/10/20
08:13
CRM

Salesforce

$200.83 /

-6.95 (-3.34%)

, CVS

CVS Health

$64.96 /

+0.87 (+1.36%)

Salesforce (CRM)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$200.83 /

-6.95 (-3.34%)

CVS CVS Health
$64.96 /

+0.87 (+1.36%)

CRM Salesforce
$200.83 /

-6.95 (-3.34%)

07/27/20 Morgan Stanley
Morgan Stanley downgrades Software industry view to In-Line from Attractive
07/14/20 Piper Sandler
Salesforce price target raised to $210 from $193 at Piper Sandler
06/24/20 Goldman Sachs
Salesforce price target raised to $220 from $204 at Goldman Sachs
06/22/20 Jefferies
Salesforce price target raised to $220 from $205 at Jefferies
CVS CVS Health
$64.96 /

+0.87 (+1.36%)

08/06/20 Deutsche Bank
CVS Health price target lowered to $104 from $109 at Deutsche Bank
07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/01/20 SVB Leerink
CVS Health reinstated with a Market Perform at SVB Leerink
06/01/20 Stephens
Molina Healthcare price target raised to $215 from $202 at Stephens
CRM Salesforce
$200.83 /

-6.95 (-3.34%)

CVS CVS Health
$64.96 /

+0.87 (+1.36%)

CRM Salesforce
$200.83 /

-6.95 (-3.34%)

CVS CVS Health
$64.96 /

+0.87 (+1.36%)

CRM Salesforce
$200.83 /

-6.95 (-3.34%)

CVS CVS Health
$64.96 /

+0.87 (+1.36%)

CRM Salesforce
$200.83 /

-6.95 (-3.34%)

CVS CVS Health
$64.96 /

+0.87 (+1.36%)

Earnings
Krystal Biotech reports Q2 EPS (37c), consensus (47c) » 08:13
08/10/20
08/10
08:13
08/10/20
08:13
KRYS

Krystal Biotech

$39.71 /

-0.29 (-0.73%)

"The future of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRYS Krystal Biotech
$39.71 /

-0.29 (-0.73%)

KRYS Krystal Biotech
$39.71 /

-0.29 (-0.73%)

03/12/20 SMBC Nikko
Krystal Biotech initiated with an Outperform at SMBC Nikko
03/10/20 H.C. Wainwright
Krystal Biotech price target raised to $68 from $59 at H.C. Wainwright
09/26/19 Guggenheim
Krystal Biotech has 'room to run' despite doubling year-to-date, says Guggenheim
09/24/19 Goldman Sachs
Krystal Biotech initiated with a Neutral at Goldman Sachs
KRYS Krystal Biotech
$39.71 /

-0.29 (-0.73%)

  • 19
    May
Hot Stocks
Vitamin Shoppe names Muriel Gonzalez Chief Merchandising and Marketing Officer » 08:12
08/10/20
08/10
08:12
08/10/20
08:12
VSI

Vitamin Shoppe

$6.50 /

+ (+0.00%)

The Vitamin Shoppe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Ovid Therapeutics reports Q2 EPS (41c), consensus (36c) » 08:12
08/10/20
08/10
08:12
08/10/20
08:12
OVID

Ovid Therapeutics

$7.19 /

+0.28 (+4.05%)

"Ovid is in an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OVID Ovid Therapeutics
$7.19 /

+0.28 (+4.05%)

OVID Ovid Therapeutics
$7.19 /

+0.28 (+4.05%)

07/14/20 Citi
Ovid Therapeutics price target raised to $9 from $8 at Citi
06/18/20 Cantor Fitzgerald
Ovid Therapeutics price target raised to $13 from $7 at Cantor Fitzgerald
05/22/20 Cantor Fitzgerald
Zynerba price target raised to $21 from $12 at Cantor Fitzgerald
05/07/20 Piper Sandler
Ovid's gaboxadol data in Fragile X 'promising,' says Piper Sandler
OVID Ovid Therapeutics
$7.19 /

+0.28 (+4.05%)

  • 04
    Oct
OVID Ovid Therapeutics
$7.19 /

+0.28 (+4.05%)

OVID Ovid Therapeutics
$7.19 /

+0.28 (+4.05%)

Earnings
Motorcar Parts not providing FY21 guidance » 08:11
08/10/20
08/10
08:11
08/10/20
08:11
MPAA

Motorcar Parts

$19.01 /

+0.74 (+4.05%)

Motorcar Parts said in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPAA Motorcar Parts
$19.01 /

+0.74 (+4.05%)

07/01/20 B. Riley FBR
Motorcar Parts transferred with Buy rating at B. Riley FBR
06/19/20 Roth Capital
Motorcar Parts assumed with a Buy at Roth Capital
11/13/19 Roth Capital
Motorcar Parts price target raised to $25 from $17 at Roth Capital
09/04/19 Roth Capital
Motorcar Parts resumed with a Buy at Roth Capital
MPAA Motorcar Parts
$19.01 /

+0.74 (+4.05%)

Hot Stocks
LiqTech reports Q2 EPS (12c), consensus (4c) » 08:11
08/10/20
08/10
08:11
08/10/20
08:11
LIQT

LiqTech

$6.70 /

-0.03 (-0.45%)

Reports Q2 revenue $4.6M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LIQT LiqTech
$6.70 /

-0.03 (-0.45%)

LIQT LiqTech
$6.70 /

-0.03 (-0.45%)

01/22/20 Lake Street
LiqTech analyst increases confidence in recovery, says Lake Street
12/17/19 Lake Street
LiqTech to recover from furnace throughput challenges, says Lake Street
11/14/19 Craig-Hallum
LiqTech post-earnings pullback a buying opportunity, says Craig-Hallum
09/06/19 Stephens
LiqTech can materially ramp revenue and profits in 2020, says Stephens
LIQT LiqTech
$6.70 /

-0.03 (-0.45%)

LIQT LiqTech
$6.70 /

-0.03 (-0.45%)

Hot Stocks
Rubius Therapeutics sees cash runway into 2022 » 08:11
08/10/20
08/10
08:11
08/10/20
08:11
RUBY

Rubius Therapeutics

$5.19 /

+0.04 (+0.78%)

As of June 30, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

03/13/20 Morgan Stanley
Morgan Stanley cuts Rubius to Equal Weight after discontinuation of PKU program
03/13/20 Guggenheim
Rubius Therapeutics price target lowered to $11 from $23 at Guggenheim
03/13/20 SVB Leerink
Rubius Therapeutics downgraded at SVB Leerink after RTX-134 discontinuation
03/13/20 Morgan Stanley
Rubius Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

Earnings
Rubius Therapeutics reports Q2 EPS (47c), consensus (50c) » 08:10
08/10/20
08/10
08:10
08/10/20
08:10
RUBY

Rubius Therapeutics

$5.19 /

+0.04 (+0.78%)

"Rubius Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

03/13/20 Morgan Stanley
Morgan Stanley cuts Rubius to Equal Weight after discontinuation of PKU program
03/13/20 Guggenheim
Rubius Therapeutics price target lowered to $11 from $23 at Guggenheim
03/13/20 SVB Leerink
Rubius Therapeutics downgraded at SVB Leerink after RTX-134 discontinuation
03/13/20 Morgan Stanley
Rubius Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

Earnings
Motorcar Parts reports Q1 EPS (16c), consensus (8c) » 08:10
08/10/20
08/10
08:10
08/10/20
08:10
MPAA

Motorcar Parts

$19.01 /

+0.74 (+4.05%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPAA Motorcar Parts
$19.01 /

+0.74 (+4.05%)

07/01/20 B. Riley FBR
Motorcar Parts transferred with Buy rating at B. Riley FBR
06/19/20 Roth Capital
Motorcar Parts assumed with a Buy at Roth Capital
11/13/19 Roth Capital
Motorcar Parts price target raised to $25 from $17 at Roth Capital
09/04/19 Roth Capital
Motorcar Parts resumed with a Buy at Roth Capital
MPAA Motorcar Parts
$19.01 /

+0.74 (+4.05%)

Hot Stocks
Royal Caribbean takes 'substantial actions' to bolster financial position » 08:10
08/10/20
08/10
08:10
08/10/20
08:10
RCL

Royal Caribbean

$52.15 /

+1.04 (+2.03%)

"We continue to take…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

07/14/20
Fly Intel: Top five analyst downgrades
07/14/20 SunTrust
Cruise Line operators downgraded at SunTrust on delayed starting dates
07/14/20 SunTrust
Royal Caribbean downgraded to Hold from Buy at SunTrust
07/14/20 Macquarie
Royal Caribbean downgraded to Neutral from Outperform at Macquarie
RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

Hot Stocks
Avadel Pharmaceuticals announces additional data from REST-ON study » 08:09
08/10/20
08/10
08:09
08/10/20
08:09
AVDL

Avadel Pharmaceuticals

$8.36 /

-0.13 (-1.53%)

Announced additional data…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVDL Avadel Pharmaceuticals
$8.36 /

-0.13 (-1.53%)

AVDL Avadel Pharmaceuticals
$8.36 /

-0.13 (-1.53%)

07/31/20
Fly Intel: Top five analyst initiations
07/30/20 Oppenheimer
Avadel Pharmaceuticals initiated with an Outperform at Oppenheimer
07/21/20 SVB Leerink
SVB Leerink bullish on Avadel Pharmaceuticals, initiates with an Outperform
07/21/20 SVB Leerink
Avadel Pharmaceuticals initiated with an Outperform at SVB Leerink
AVDL Avadel Pharmaceuticals
$8.36 /

-0.13 (-1.53%)

  • 29
    Apr
AVDL Avadel Pharmaceuticals
$8.36 /

-0.13 (-1.53%)

AVDL Avadel Pharmaceuticals
$8.36 /

-0.13 (-1.53%)

Recommendations
BlackLine price target raised to $80 from $64 at Truist » 08:09
08/10/20
08/10
08:09
08/10/20
08:09
BL

BlackLine

$79.32 /

-12.34 (-13.46%)

Truist analyst Terry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BL BlackLine
$79.32 /

-12.34 (-13.46%)

BL BlackLine
$79.32 /

-12.34 (-13.46%)

07/20/20 JMP Securities
BlackLine price target raised to $95 from $62 at JMP Securities
06/29/20 Goldman Sachs
BlackLine price target raised to $71 from $54 at Goldman Sachs
06/18/20 Baird
BlackLine price target raised to $90 from $70 at Baird
05/28/20 Piper Sandler
BlackLine price target raised to $78 from $69 at Piper Sandler
BL BlackLine
$79.32 /

-12.34 (-13.46%)

Hot Stocks
Capstone Turbine secures order for three C65 ICHP microturbines from hotel chain » 08:09
08/10/20
08/10
08:09
08/10/20
08:09
CPST

Capstone Turbine

$4.56 /

+0.16 (+3.64%)

Capstone Turbine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPST Capstone Turbine
$4.56 /

+0.16 (+3.64%)

CPST Capstone Turbine
$4.56 /

+0.16 (+3.64%)

06/30/20 Maxim
Capstone Turbine downgraded to Hold from Buy at Maxim
11/11/19 Lake Street
Capstone Turbine price target lowered to $5 from $30 at Lake Street
11/08/19 Oppenheimer
Capstone Turbine downgraded to Perform from Outperform at Oppenheimer
11/08/19 Oppenheimer
Capstone Turbine downgraded to Perform from Outperform at Oppenheimer
CPST Capstone Turbine
$4.56 /

+0.16 (+3.64%)

Hot Stocks
PPL to sell UK utility business » 08:09
08/10/20
08/10
08:09
08/10/20
08:09
PPL

PPL Corp.

$27.13 /

+0.635 (+2.40%)

PPL announced that it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PPL PPL Corp.
$27.13 /

+0.635 (+2.40%)

PPL PPL Corp.
$27.13 /

+0.635 (+2.40%)

07/10/20 Morgan Stanley
PPL Corp. has negative read from Ofgem decision, says Morgan Stanley
06/09/20 Seaport Global
PPL Corp. downgraded to Sell following outperformance at Seaport Global
06/09/20 Seaport Global
PPL Corp. downgraded to Sell from Neutral at Seaport Global
05/29/20 Mizuho
Mizuho upgrades PPL to Buy with 'attractive' 6.1% yield
PPL PPL Corp.
$27.13 /

+0.635 (+2.40%)

PPL PPL Corp.
$27.13 /

+0.635 (+2.40%)

Recommendations
Ameren price target raised to $93 from $84 at Wells Fargo » 08:09
08/10/20
08/10
08:09
08/10/20
08:09
AEE

Ameren

$82.17 /

+1.09 (+1.34%)

Wells Fargo analyst Neil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AEE Ameren
$82.17 /

+1.09 (+1.34%)

AEE Ameren
$82.17 /

+1.09 (+1.34%)

08/03/20 Wolfe Research
Evergy downgraded to Peer Perform from Outperform at Wolfe Research
04/24/20 Morgan Stanley
Federal support for renewables could come in summer, says Morgan Stanley
04/22/20 B. Riley FBR
FCC Chair post step forward for Anterix monetization, says B. Riley FBR
04/22/20 B. Riley FBR
FCC Chair post step forward for Anterix monetization, says B. Riley FBR
AEE Ameren
$82.17 /

+1.09 (+1.34%)

AEE Ameren
$82.17 /

+1.09 (+1.34%)

Earnings
Avadel Pharmaceuticals reports Q2 EPS 49c, consensus (10c) » 08:08
08/10/20
08/10
08:08
08/10/20
08:08
AVDL

Avadel Pharmaceuticals

$8.36 /

-0.13 (-1.53%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVDL Avadel Pharmaceuticals
$8.36 /

-0.13 (-1.53%)

AVDL Avadel Pharmaceuticals
$8.36 /

-0.13 (-1.53%)

07/31/20
Fly Intel: Top five analyst initiations
07/30/20 Oppenheimer
Avadel Pharmaceuticals initiated with an Outperform at Oppenheimer
07/21/20 SVB Leerink
SVB Leerink bullish on Avadel Pharmaceuticals, initiates with an Outperform
07/21/20 SVB Leerink
Avadel Pharmaceuticals initiated with an Outperform at SVB Leerink
AVDL Avadel Pharmaceuticals
$8.36 /

-0.13 (-1.53%)

  • 29
    Apr
AVDL Avadel Pharmaceuticals
$8.36 /

-0.13 (-1.53%)

AVDL Avadel Pharmaceuticals
$8.36 /

-0.13 (-1.53%)

Recommendations
PRA Health price target raised to $108 from $92 at Mizuho » 08:08
08/10/20
08/10
08:08
08/10/20
08:08
PRAH

PRA Health

$106.54 /

-2.21 (-2.03%)

Mizuho analyst Ann Hynes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRAH PRA Health
$106.54 /

-2.21 (-2.03%)

PRAH PRA Health
$106.54 /

-2.21 (-2.03%)

07:27 Today BofA
PRA Health downgraded to Underperform from Buy at BofA
07/27/20 SunTrust
SunTrust raises price targets on select late-stage CROs
05/04/20 SunTrust
PRA Health price target raised to $103 from $89 at SunTrust
05/01/20 William Blair
PRA Health downgraded to Market Perform from Outperform at William Blair
PRAH PRA Health
$106.54 /

-2.21 (-2.03%)

  • 04
    Sep
Syndicate
Baudax Bio files $100M mixed securities shelf  08:08
08/10/20
08/10
08:08
08/10/20
08:08
BXRX

Baudax Bio

$3.45 /

-0.025 (-0.72%)

 
ShowHide Related Items >><<
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

05/15/20 JMP Securities
Baudax Bio initiated with an Outperform at JMP Securities
02/21/20 Piper Sandler
Baudax Bio price target raised to $14 from $11 at Piper Sandler
11/22/19 Janney Montgomery Scott
Baudax Bio initiated with a Buy at Janney Montgomery Scott
11/22/19 Piper Jaffray
Baudax Bio initiated with an Overweight at Piper Jaffray
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

  • 24
    Mar
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

Hot Stocks
WhiteHorse Finance reports Q2 Core EPS 25.5c, consensus 28c » 08:07
08/10/20
08/10
08:07
08/10/20
08:07
WHF

WhiteHorse Finance

$9.92 /

+0.18 (+1.85%)

Reports Q2 net increase…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WHF WhiteHorse Finance
$9.92 /

+0.18 (+1.85%)

WHF WhiteHorse Finance
$9.92 /

+0.18 (+1.85%)

05/12/20 National Securities
WhiteHorse Finance upgraded to Buy from Neutral at National Securities
03/24/20 B. Riley FBR
WhiteHorse Finance downgraded to Neutral from Buy at B. Riley FBR
03/17/20 National Securities
WhiteHorse Finance upgraded to Buy from Neutral at National Securities
03/03/20 National Securities
WhiteHorse Finance downgraded to Neutral from Buy at National Securities
WHF WhiteHorse Finance
$9.92 /

+0.18 (+1.85%)

  • 05
    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.